Jefferies & Company Maintains eHealth Hold Rating

Improvement in eHealth, Inc.'s EHTH Y/Y applications growth came at a higher marketing cost, and resulted in in-line 3Q results. “Visibility into the details of heath care reforms and MLR changes remains poor, keeping us on the sidelines,” Jefferies & Company writes. “We're maintaining a Hold rating, while raising our fair value to $14.” 3Q10 results came in-line with consensus for revenue and EPS, while applications grew 9% Y/Y, up from (3%) in 2Q10. Adds Jefferies & Company, “At $13.47, EHTH is trading at EV/EBITDA of 5.5x and a P/E of 23.6x our FY10 estimates. Our $14 PT is derived using a five-year DCF and implies an EV/EBITDA multiple of 5.1x. Risks include carrier concentration and consolidation, regulatory changes, and investments in new initiatives.” eHealth currently trades at $13.47.
Market News and Data brought to you by Benzinga APIs
Comments
Loading...
date
ticker
name
Price Target
Upside/Downside
Recommendation
Firm
Posted In: Analyst RatingseHealthJefferies & Company
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!